Success Metrics

Active Trials
7(88%)

Phase Distribution

Ph phase_1
2
25%
Ph phase_2
1
13%
Ph not_applicable
4
50%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

8

all time

Status Distribution
Active(8)

Detailed Status

Recruiting7
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
7
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 12 (28.6%)
Phase 21 (14.3%)
N/A4 (57.1%)

Trials by Status

not_yet_recruiting113%
recruiting788%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8